BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12119910)

  • 1. [Lipid control in the double pack. Combined drugs to achieve the goal].
    MMW Fortschr Med; 2002 Jun; 144(23):53. PubMed ID: 12119910
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
    MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 Apr; 145(16):48-50. PubMed ID: 14606402
    [No Abstract]   [Full Text] [Related]  

  • 4. [Statins plus cholesterol resorption inhibitor. LDL goal values attainable].
    MMW Fortschr Med; 2002 Sep; 144(38):56. PubMed ID: 12395708
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia.
    Pitsavos C; Skoumas I; Tousoulis D; Metalinos G; Masoura C; Chrysohoou C; Papadimitriou L; Giotsas N; Toutouza M; Antoniades C; Stefanadis C
    Int J Cardiol; 2009 May; 134(2):280-1. PubMed ID: 18353459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommended LDL value far lower. How does one achieve this goal?].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219116
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cholesterol resorption inhibition prevents high statin doses. Lipid lowering in double-pack].
    MMW Fortschr Med; 2002 Nov; 144(48):60. PubMed ID: 12532550
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ezetimib plus statin combination. A strong duo].
    MMW Fortschr Med; 2002 Nov; 144(48):53. PubMed ID: 12532547
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypercholesterolemia: when statins are not enough or not tolerated. With combination therapy to LDL cholesterol target goal].
    MMW Fortschr Med; 2012 Jul; 154(13):86-7. PubMed ID: 22957390
    [No Abstract]   [Full Text] [Related]  

  • 11. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
    MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
    [No Abstract]   [Full Text] [Related]  

  • 13. [Controlling LDL cholesterol from 2 sides. "I have never seen such low LDL values"].
    MMW Fortschr Med; 2003 May; 145(20):59. PubMed ID: 12822234
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lowering cholesterol becomes easier. Combining instead of increasing dosage].
    MMW Fortschr Med; 2003 Jan; 145(3-4):59. PubMed ID: 12619241
    [No Abstract]   [Full Text] [Related]  

  • 15. [Statins remain the standard. New methods for lipid lowering therapy].
    Aumiller J
    MMW Fortschr Med; 2001 Oct; 143(42):16-7. PubMed ID: 11697281
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination therapy of hypercholesterolemia].
    Vanhanen H; Gylling H; Miettinen TA
    Duodecim; 2002; 118(19):1967-73. PubMed ID: 12462803
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin + ezetimibe: a combination with no proven advantages.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
    Robinson JG; Davidson MH
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New studies of high dosage statins and fibrates. How is lipid lowering therapy changing? (interview by Dr. med. Dirk Einecke)].
    Klose G
    MMW Fortschr Med; 2005 Dec; 147(49-50):20. PubMed ID: 16401005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.